CN112868946A - Kiwi fruit compound beverage and preparation method thereof - Google Patents
Kiwi fruit compound beverage and preparation method thereof Download PDFInfo
- Publication number
- CN112868946A CN112868946A CN202010618832.5A CN202010618832A CN112868946A CN 112868946 A CN112868946 A CN 112868946A CN 202010618832 A CN202010618832 A CN 202010618832A CN 112868946 A CN112868946 A CN 112868946A
- Authority
- CN
- China
- Prior art keywords
- parts
- kiwi fruit
- juice
- grape
- hawthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000298697 Actinidia deliciosa Species 0.000 title claims abstract description 68
- 235000009436 Actinidia deliciosa Nutrition 0.000 title claims abstract description 68
- 235000013361 beverage Nutrition 0.000 title claims abstract description 38
- 150000001875 compounds Chemical class 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 244000078534 Vaccinium myrtillus Species 0.000 claims abstract description 52
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 28
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 28
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 28
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 28
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 28
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 28
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 28
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 28
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 28
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 28
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 28
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 28
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 27
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 27
- 235000021014 blueberries Nutrition 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 26
- 240000000249 Morus alba Species 0.000 claims abstract description 25
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 24
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 24
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 24
- 235000017848 Rubus fruticosus Nutrition 0.000 claims abstract description 24
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 24
- 229930006000 Sucrose Natural products 0.000 claims abstract description 21
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 21
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 21
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 21
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 21
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 21
- 229960004793 sucrose Drugs 0.000 claims abstract description 21
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 19
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 49
- 240000006432 Carica papaya Species 0.000 claims description 27
- 108010059820 Polygalacturonase Proteins 0.000 claims description 10
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 235000019674 grape juice Nutrition 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 238000009924 canning Methods 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 235000010352 sodium erythorbate Nutrition 0.000 claims description 5
- 239000004320 sodium erythorbate Substances 0.000 claims description 5
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000000265 homogenisation Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 28
- 235000012000 cholesterol Nutrition 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 230000001603 reducing effect Effects 0.000 abstract description 11
- 230000032683 aging Effects 0.000 abstract description 8
- 230000035622 drinking Effects 0.000 abstract description 5
- 230000003796 beauty Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000189799 Asimina triloba Species 0.000 abstract 1
- 235000021029 blackberry Nutrition 0.000 description 17
- 235000013399 edible fruits Nutrition 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 229940055729 papain Drugs 0.000 description 3
- 235000019834 papain Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000010016 myocardial function Effects 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 108090000746 Chymosin Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940080701 chymosin Drugs 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- LUKBXSAWLPMMSZ-UHFFFAOYSA-N resveratrol Chemical compound C1=CC(O)=CC=C1C=CC1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-UHFFFAOYSA-N 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000007507 senile plaque formation Effects 0.000 description 1
- 208000022288 senile plaque formation Diseases 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kiwi fruit compound beverage and a preparation method thereof, wherein the kiwi fruit compound beverage is prepared from the following components in parts by weight: 40-60 parts of kiwi fruit, 20-30 parts of mulberry, 10-20 parts of pawpaw, 10-20 parts of blueberry, 15-25 parts of grape, 10-20 parts of hawthorn, 5-10 parts of blackberry, 5-10 parts of medlar, 300 parts of water 200 and 10-20 parts of cane sugar. The kiwi fruit compound beverage prepared by the invention has the health-care effects of maintaining beauty and keeping young, preventing aging, reducing cholesterol and blood fat and the like, is suitable for drinking at multiple age groups, and has the advantages of simple preparation method, low cost and no toxic or side effect.
Description
Technical Field
The invention relates to the technical field of beverage preparation, and particularly relates to a kiwi fruit compound beverage and a preparation method thereof.
Background
Kiwifruit (Actinidia chinensis Planch), also known as exotic fruit, is generally oval in shape, green-brown in early appearance and reddish-brown after ripening, with dense villi covering the epidermis, in which there is a bright green pulp and a row of black or red seeds. One fifth of the fiber contained in the fruit is pectin, especially the contacting part of the peel and pulp. Pectin can reduce blood cholesterol concentration and prevent cardiovascular diseases. The dietary fiber contained in the health-care food not only can reduce cholesterol, but also can help digestion, prevent constipation and remove harmful metabolites in the body. Reducing blood lipid, inhibiting cholesterol deposition on inner wall of artery, preventing and treating arteriosclerosis, improving myocardial function, and preventing and treating heart disease. The vitamin C rich in the kiwi fruit is used as an antioxidant, can effectively inhibit nitration reaction and prevent cancer. The Chinese gooseberry also is a tonic product, and the nutrient substances in the Chinese gooseberry can obviously improve the activity of the human body, promote the metabolism, coordinate the functions of the human body, block carcinogens, strengthen the health and delay senility.
The kiwi fruit is rich and comprehensive in nutrition, but the processing of the kiwi fruit only stops on the primary processing of kiwi fruit slices and the like at present, the variety is less, the variety is single, and the demand of consumers cannot be met.
Disclosure of Invention
Aiming at the problems in the prior art, the invention provides the kiwi fruit compound beverage and the preparation method thereof, the kiwi fruit compound beverage has the effects of reducing cholesterol, reducing blood pressure, maintaining beauty and keeping young, preventing aging, softening blood vessels and preventing arteriosclerosis, can improve immunity, is suitable for drinking at multiple ages, and is simple in preparation method and low in cost.
In order to achieve the purpose, the invention adopts the technical scheme that:
a kiwi fruit compound beverage is prepared from the following components in parts by weight: 40-60 parts of kiwi fruit, 20-30 parts of mulberry, 10-20 parts of pawpaw, 10-20 parts of blueberry, 15-25 parts of grape, 10-20 parts of hawthorn, 5-10 parts of blackberry, 5-10 parts of medlar, 300 parts of water 200 and 10-20 parts of cane sugar.
Preferably, the composition comprises the following components in parts by weight: 45-55 parts of kiwi fruit, 22-28 parts of mulberry, 12-18 parts of pawpaw, 12-18 parts of blueberry, 18-22 parts of grape, 12-18 parts of hawthorn, 6-8 parts of blackberry, 6-8 parts of medlar, 280 parts of water 220 and 12-18 parts of cane sugar.
In any of the above schemes, the composition preferably comprises the following components in parts by weight: 40 parts of kiwi fruit, 20 parts of mulberry, 10 parts of pawpaw, 10 parts of blueberry, 15 parts of grape, 10 parts of hawthorn, 5 parts of blackberry, 5 parts of medlar, 200 parts of water and 10 parts of cane sugar.
In any of the above schemes, the composition preferably comprises the following components in parts by weight: 45 parts of kiwi fruit, 22 parts of mulberry, 12 parts of pawpaw, 12 parts of blueberry, 18 parts of grape, 12 parts of hawthorn, 6 parts of blackberry, 6 parts of medlar, 220 parts of water and 12 parts of cane sugar.
In any of the above schemes, the composition preferably comprises the following components in parts by weight: 55 parts of kiwi fruit, 28 parts of mulberry, 18 parts of pawpaw, 18 parts of blueberry, 22 parts of grape, 18 parts of hawthorn, 8 parts of blackberry, 8 parts of medlar, 280 parts of water and 18 parts of cane sugar.
In any of the above schemes, the composition preferably comprises the following components in parts by weight: 60 parts of kiwi fruit, 30 parts of mulberry, 20 parts of pawpaw, 20 parts of blueberry, 25 parts of grape, 20 parts of hawthorn, 10 parts of blackberry, 10 parts of medlar, 300 parts of water and 20 parts of cane sugar.
The invention also provides a preparation method of the kiwi fruit compound beverage, which comprises the following steps:
weighing raw materials according to the weight ratio, peeling, removing cores, cleaning all the raw materials with saline water, and fishing out;
respectively adding 0.02-0.03% of sodium erythorbate, mixing and grinding uniformly, and stirring to obtain a paste for later use;
step (3), adding pectinase for enzymolysis respectively;
respectively filtering, centrifuging and removing residues to obtain kiwi fruit juice, mulberry juice, papaya juice, blueberry juice, grape juice, hawthorn juice, blackberry juice and medlar juice;
and (5) uniformly mixing the kiwi fruit juice, the mulberry juice, the papaya juice, the blueberry juice, the grape juice, the hawthorn juice, the blackberry juice and the medlar juice obtained in the step (4) with water and cane sugar, homogenizing, sterilizing and canning.
In any of the above schemes, preferably, in step (3), the addition amount of pectinase is 0.15-0.3%, and the enzymolysis is carried out at 35-45 ℃ for 40-80 min.
In any of the above schemes, the step (4) is preferably carried out by 80-100 mesh filtration and centrifugation at 3000r/min for 20-25 min.
In any of the above schemes, preferably, in the step (5), the homogenization treatment is carried out at 45-65 ℃ and the homogenization pressure is 22-32 MPa.
The formula of the invention comprises:
the kiwi fruit contains 12 kinds of amino acids, rich protein and minerals such as calcium, phosphorus, potassium, iron and the like, and is one of fruits with rich nutrition. The fructus Actinidiae chinensis can be used for preventing senile osteoporosis; inhibiting the deposition of cholesterol on the inner wall of the artery, thereby preventing and treating arteriosclerosis; can improve myocardial function, and prevent and treat heart disease. In the aspect of resisting cancer, the composition has the effect of inhibiting the mutagenesis of tissues by nitrosamine in intestinal tracts. It also has effects in preventing excessive peroxide generation in vivo, nourishing, strengthening body constitution, clearing away heat, promoting urination, invigorating stomach, moistening dryness, preventing senile plaque formation, and delaying aging.
Mulberries have a long history of wine brewing, and mulberry wine contains abundant bioactive components and nutrients such as anthocyanin, resveratrol, amino acids, vitamins and the like. The mulberry wine contains eighteen amino acids and multiple trace elements required by human body, and the trace elements have ten great effects on treatment and protection of human heart and immune system.
The blueberry fruits are rich in vitamin E, vitamin A, vitamin B, superoxide dismutase (SOD), arbutin, protein, anthocyanin, edible fiber, abundant potassium, iron, zinc, calcium and other mineral elements besides conventional sugar, acid and vitamin C, the vitamins are all higher than those of other fruits, and the blueberry fruits are also high in trace elements and belong to fruits with high amino acid, high copper, high zinc and high iron. Protecting eyes and enhancing eyesight; enhancing the autoimmunity; anti-oxidation function and aging slowing; enhancing memory; the nutrient substances contained in the blueberry with the anti-cancer function have the inhibiting effect on middle and early cancers. Anthocyanidin in blueberry fruit is a very strong antioxidant, and can help prevent the formation of intra-arterial plaque and various cancers and reduce the possibility of cancer.
Grape, relief of hypoglycemia: the glucose is mainly glucose and can be quickly absorbed by human body. When a human body has hypoglycemia, if the grape juice is drunk in time, the symptoms can be quickly relieved; and (3) thrombus prevention: french scientists find that the grape can better prevent the formation of thrombus than aspirin, reduce the serum cholesterol level of a human body, reduce the cohesion of platelets and play a certain role in preventing cardiovascular and cerebrovascular diseases; anti-aging: grape seeds are said to be true antioxidant giant stars. The antioxidation is an anti-aging method, so the grape seeds can resist aging and can clear free radicals in the body, and people can keep youth forever; the grape contains an anticancer trace element (resveratrol) which can prevent canceration of healthy cells and prevent cancer cells from spreading. The grape juice can help the organ plant operation patient to reduce rejection reaction and promote early recovery; strengthening spleen and stomach: the digestion is facilitated, and the grapes can be eaten properly, so that the spleen and the stomach can be strengthened; relieving fatigue is of great benefit to neurasthenia and over-fatigue.
Fructus crataegi has effects in reducing blood lipid, preventing and treating cardiovascular diseases, lowering blood pressure and cholesterol, softening blood vessel, promoting urination, and tranquilizing mind; the hawthorn is adopted in a plurality of medicines for helping digestion; the hawthorn has the effects of promoting blood circulation and removing blood stasis, is beneficial to relieving the local blood stasis state and has auxiliary curative effect on traumatic injury; can be used for treating diarrhea, and fructus crataegi contains components for relieving asthma, eliminating phlegm, inhibiting bacteria, and treating abdominal pain and diarrhea; the recovery of the uterus is promoted, the hawthorn has the contraction effect on the uterus, has the effect of hastening parturition when the pregnant woman is in parturition, and can promote the recovery of the postpartum uterus; the hawthorn fruit has the effects of resisting aging, preventing and resisting cancer, and flavonoids, vitamin C, carotene and other substances contained in the hawthorn fruit can block and reduce the generation of free radicals, can enhance the immunity of the organism, and has the effects of preventing aging.
The pawpaw has the effects of tonifying spleen to promote digestion and can decompose fat into fatty acid; modern medicine finds that the pawpaw contains an enzyme which can digest protein and is beneficial to human body to digest and absorb food, so that the pawpaw has the effects of tonifying spleen and helping digestion; the papain and papain have the effects of resisting mycobacterium tuberculosis and parasites such as tapeworm, ascaris, whipworm and amoeba protozoon, so that the papain and the caricin can be used for killing pests and tuberculosis; the product has effects in promoting lactation, resisting cancer, promoting milk secretion of chymosin in melon, and resisting lymphoid leukemia, so it can be used for promoting lactation and treating lymphoid leukemia (leukemia); supplementing nutrition and improving disease resistance; contains a large amount of water, carbohydrate, protein, fat, various vitamins and various amino acids necessary for human body, can effectively supplement nutrients for human body, and enhance the disease resistance of organism; the papaya alkali contained in the papaya flesh has the effect of relieving spasm pain, and has an obvious treatment effect on gastrocnemius spasm.
Blackberries, which aid digestion, have a higher cellulose content than most other fruits. One blackberry contains 8 g of cellulose, which is higher than the cellulose content of two cups of wheat, and is helpful for better meeting the daily demand of 25 g of cellulose. Cellulose is vital to digestive health, helping to maintain healthy body weight and reduce high cholesterol. Improving immunity and reducing anemia risk. Strengthening bones, resisting cancer, etc.
The medlar has the functions of tonifying the kidney and replenishing vital essence, nourishing the liver and improving eyesight, enriching the blood and soothing the nerves, promoting the production of body fluid to quench thirst, moistening the lung and relieving cough. It is indicated for liver and kidney yin deficiency, soreness and weakness of waist and knees, dizziness, blurred vision, hyperdacryosis, cough due to asthenia, diabetes, and spermatorrhea.
Advantageous effects
The invention provides a kiwi fruit compound beverage and a preparation method thereof, wherein the kiwi fruit compound beverage is prepared from the following components in parts by weight: 40-60 parts of kiwi fruit, 20-30 parts of mulberry, 10-20 parts of pawpaw, 10-20 parts of blueberry, 15-25 parts of grape, 10-20 parts of hawthorn, 5-10 parts of blackberry, 5-10 parts of medlar, 300 parts of water 200 and 10-20 parts of cane sugar. The kiwi fruit compound beverage prepared by the invention has the health-care effects of maintaining beauty and keeping young, preventing aging, reducing cholesterol and blood fat and the like, is suitable for drinking at multiple age groups, and is simple in preparation method and low in cost.
Detailed Description
Example one
A kiwi fruit compound beverage is prepared from the following components in parts by weight: 40 parts of kiwi fruit, 20 parts of mulberry, 10 parts of pawpaw, 10 parts of blueberry, 15 parts of grape, 10 parts of hawthorn, 5 parts of blackberry, 5 parts of medlar, 200 parts of water and 10 parts of cane sugar.
The preparation method of the kiwi fruit compound beverage comprises the following steps:
weighing raw materials according to the weight ratio, peeling, removing cores, cleaning all the raw materials with saline water, and fishing out;
respectively adding 0.02-0.03% of sodium erythorbate, mixing and grinding uniformly, and stirring to obtain a paste for later use;
step (3), adding pectinase for enzymolysis respectively, wherein the addition amount of the pectinase is 0.15-0.3%, and the enzymolysis is carried out at 35-45 ℃ for 40-80 min;
filtering the obtained enzymolysis liquid by 80-100 meshes, centrifuging at 3000r/min for 20-25min at 2500-;
and (5) uniformly mixing the kiwi fruit juice, the mulberry juice, the papaya juice, the blueberry juice, the grape juice, the hawthorn juice, the blackberry juice and the medlar juice obtained in the step (4) with water and cane sugar, homogenizing at 45-65 ℃, sterilizing and canning, wherein the homogenizing pressure is 22-32 MPa.
Example two
A kiwi fruit compound beverage is prepared from the following components in parts by weight: 45 parts of kiwi fruit, 22 parts of mulberry, 12 parts of pawpaw, 12 parts of blueberry, 18 parts of grape, 12 parts of hawthorn, 6 parts of blackberry, 6 parts of medlar, 220 parts of water and 12 parts of cane sugar.
The preparation method of the kiwi fruit compound beverage comprises the following steps:
weighing raw materials according to the weight ratio, peeling, removing cores, cleaning all the raw materials with saline water, and fishing out;
respectively adding 0.02-0.03% of sodium erythorbate, mixing and grinding uniformly, and stirring to obtain a paste for later use;
step (3), adding pectinase for enzymolysis respectively, wherein the addition amount of the pectinase is 0.15-0.3%, and the enzymolysis is carried out at 35-45 ℃ for 40-80 min;
filtering the obtained enzymolysis liquid by 80-100 meshes, centrifuging at 3000r/min for 20-25min at 2500-;
and (5) uniformly mixing the kiwi fruit juice, the mulberry juice, the papaya juice, the blueberry juice, the grape juice, the hawthorn juice, the blackberry juice and the medlar juice obtained in the step (4) with water and cane sugar, homogenizing at 45-65 ℃, sterilizing and canning, wherein the homogenizing pressure is 22-32 MPa.
EXAMPLE III
A kiwi fruit compound beverage is prepared from the following components in parts by weight: 60 parts of kiwi fruit, 30 parts of mulberry, 20 parts of pawpaw, 20 parts of blueberry, 25 parts of grape, 20 parts of hawthorn, 10 parts of blackberry, 10 parts of medlar, 300 parts of water and 20 parts of cane sugar.
The preparation method of the kiwi fruit compound beverage comprises the following steps:
weighing raw materials according to the weight ratio, peeling, removing cores, cleaning all the raw materials with saline water, and fishing out;
respectively adding 0.02-0.03% of sodium erythorbate, mixing and grinding uniformly, and stirring to obtain a paste for later use;
step (3), adding pectinase for enzymolysis respectively, wherein the addition amount of the pectinase is 0.15-0.3%, and the enzymolysis is carried out at 35-45 ℃ for 40-80 min;
filtering the obtained enzymolysis liquid by 80-100 meshes, centrifuging at 3000r/min for 20-25min at 2500-;
and (5) uniformly mixing the kiwi fruit juice, the mulberry juice, the papaya juice, the blueberry juice, the grape juice, the hawthorn juice, the blackberry juice and the medlar juice obtained in the step (4) with water and cane sugar, homogenizing at 45-65 ℃, sterilizing and canning, wherein the homogenizing pressure is 22-32 MPa.
Example four
When the kiwi fruit compound beverage prepared in the embodiment 1 of the invention is given to a patient with dyslipidemia for drinking in 5 months-2019 and 4 months in 2018, 138 clinical observations are summarized as follows:
(ii) standard of therapeutic efficacy
1. The medicine is taken three times a day, one bottle is taken each time, the capacity of each bottle is 150ml, after the medicine is continuously taken for 8-12 weeks, the main symptoms of headache and dizziness disappear and get better, the concentration of the total cholesterol in blood plasma is in a normal range, the concentration of the total cholesterol in blood plasma is checked to be normal (the concentration of the total cholesterol in blood plasma is less than 100mg/dl) or is obviously reduced compared with the original concentration, and the medicine is close to normal and has obvious curative effect.
2. The total cholesterol concentration in blood plasma is obviously reduced compared with the original concentration after continuously taking the product for 8-12 weeks, and the product is effective for treatment.
3. The product is taken three times a day, one bottle each time, each bottle has a capacity of 150ml, and after the product is continuously taken for 8-12 weeks, symptoms are relieved, but the time is good and bad, and the blood plasma total cholesterol concentration is not obviously improved before, so that the treatment is ineffective.
(II) analysis of therapeutic Effect
138 cases are accepted in clinical trials, and 8-12 weeks of treatment is completed. The personal information of the patients and the conditions after administration are shown in Table 1 below
TABLE 1 patient personal information and treatment status
The data show that the kiwi fruit compound beverage has an obvious blood fat reducing effect after being taken. Among 138 patients, the curative effect is remarkable for 120 patients, accounting for 86.9 percent; the treatment effect is 7 cases, accounting for 5.0%; treatment was not effective in 11 cases, accounting for 7.9%. The data show that the kiwi fruit compound beverage has an obvious effect of reducing blood fat and a good effect of reducing blood fat. The kiwi fruit compound beverage prepared by the invention has the health-care effects of reducing cholesterol and blood fat and the like, is suitable for drinking at multiple age groups, and has the advantages of simple preparation method, low cost and no toxic or side effect.
The technical solutions provided by the embodiments of the present invention are described in detail above, and the principles and embodiments of the present invention are explained herein by using specific examples, and the descriptions of the embodiments are only used to help understanding the principles of the embodiments of the present invention; meanwhile, for a person skilled in the art, according to the embodiments of the present invention, there may be variations in the specific implementation manners and application ranges, and in summary, the content of the present description should not be construed as a limitation to the present invention.
Claims (9)
1. The kiwi fruit compound beverage is characterized by being prepared from the following components in parts by weight: 40-60 parts of kiwi fruit, 20-30 parts of mulberry, 10-20 parts of pawpaw, 10-20 parts of blueberry, 15-25 parts of grape, 10-20 parts of hawthorn, 5-10 parts of blackberry, 5-10 parts of medlar, 300 parts of water 200 and 10-20 parts of cane sugar.
2. The kiwi fruit composite beverage according to claim 1, wherein the kiwi fruit composite beverage comprises the following components in parts by weight: 45-55 parts of kiwi fruit, 22-28 parts of mulberry, 12-18 parts of pawpaw, 12-18 parts of blueberry, 18-22 parts of grape, 12-18 parts of hawthorn, 6-8 parts of blackberry, 6-8 parts of medlar, 280 parts of water 220 and 12-18 parts of cane sugar.
3. The kiwi fruit composite beverage according to claim 1, wherein the kiwi fruit composite beverage comprises the following components in parts by weight: 40 parts of kiwi fruit, 20 parts of mulberry, 10 parts of pawpaw, 10 parts of blueberry, 15 parts of grape, 10 parts of hawthorn, 5 parts of blackberry, 5 parts of medlar, 200 parts of water and 10 parts of cane sugar.
4. The kiwi fruit composite beverage according to claim 1, wherein the kiwi fruit composite beverage comprises the following components in parts by weight: 55 parts of kiwi fruit, 28 parts of mulberry, 18 parts of pawpaw, 18 parts of blueberry, 22 parts of grape, 18 parts of hawthorn, 8 parts of blackberry, 8 parts of medlar, 280 parts of water and 18 parts of cane sugar.
5. The kiwi fruit composite beverage according to claim 1, wherein the kiwi fruit composite beverage comprises the following components in parts by weight: 60 parts of kiwi fruit, 30 parts of mulberry, 20 parts of pawpaw, 20 parts of blueberry, 25 parts of grape, 20 parts of hawthorn, 10 parts of blackberry, 10 parts of medlar, 300 parts of water and 20 parts of cane sugar.
6. The method for preparing the kiwi fruit complex beverage according to any one of claims 1-5, comprising the steps of:
weighing raw materials according to the weight ratio, peeling, removing cores, cleaning all the raw materials with saline water, and fishing out;
respectively adding 0.02-0.03% of sodium erythorbate, mixing and grinding uniformly, and stirring to obtain a paste for later use;
step (3), adding pectinase for enzymolysis respectively;
respectively filtering, centrifuging and removing residues to obtain kiwi fruit juice, mulberry juice, papaya juice, blueberry juice, grape juice, hawthorn juice, blackberry juice and medlar juice;
and (5) uniformly mixing the kiwi fruit juice, the mulberry juice, the papaya juice, the blueberry juice, the grape juice, the hawthorn juice, the blackberry juice and the medlar juice obtained in the step (4) with water and cane sugar, homogenizing, sterilizing and canning.
7. The preparation method of the kiwi fruit composite beverage according to claim 6, wherein in the step (3), the addition amount of pectinase is 0.15-0.3%, and the enzymolysis is carried out at 35-45 ℃ for 40-80 min.
8. The method for preparing the kiwi fruit composite beverage as claimed in claim 6, wherein in the step (4), the kiwi fruit composite beverage is filtered by 80-100 meshes and centrifuged at 3000r/min for 20-25 min.
9. The preparation method of the kiwi fruit composite beverage according to claim 6, wherein in the step (5), homogenization treatment is performed at 45-65 ℃ and the homogenization pressure is 22-32 MPa.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010618832.5A CN112868946A (en) | 2020-07-01 | 2020-07-01 | Kiwi fruit compound beverage and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010618832.5A CN112868946A (en) | 2020-07-01 | 2020-07-01 | Kiwi fruit compound beverage and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112868946A true CN112868946A (en) | 2021-06-01 |
Family
ID=76042890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010618832.5A Pending CN112868946A (en) | 2020-07-01 | 2020-07-01 | Kiwi fruit compound beverage and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112868946A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101288493A (en) * | 2008-05-28 | 2008-10-22 | 林伟锋 | Kiwifruit whole fruit protoplasm and production method thereof |
CN103300442A (en) * | 2013-06-25 | 2013-09-18 | 徐州工程学院 | Green wheat berry and kiwi fruit composite beverage and preparing method thereof |
CN107083293A (en) * | 2017-05-31 | 2017-08-22 | 重庆文理学院 | A kind of Yangtao wine and preparation method thereof |
CN107467318A (en) * | 2017-09-29 | 2017-12-15 | 重庆文理学院 | A kind of kiwi berry fruit tea and preparation method thereof |
-
2020
- 2020-07-01 CN CN202010618832.5A patent/CN112868946A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101288493A (en) * | 2008-05-28 | 2008-10-22 | 林伟锋 | Kiwifruit whole fruit protoplasm and production method thereof |
CN103300442A (en) * | 2013-06-25 | 2013-09-18 | 徐州工程学院 | Green wheat berry and kiwi fruit composite beverage and preparing method thereof |
CN107083293A (en) * | 2017-05-31 | 2017-08-22 | 重庆文理学院 | A kind of Yangtao wine and preparation method thereof |
CN107467318A (en) * | 2017-09-29 | 2017-12-15 | 重庆文理学院 | A kind of kiwi berry fruit tea and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104287013B (en) | A kind of reducing blood lipid function of blood sugar reduction sexual health vinegar beverage and production technology thereof | |
CN103054113B (en) | Composite fruit-vegetable juice beverage with blood sugar decreasing effect | |
CN102265951A (en) | Tea for homolysis and lipopenicillinase and preparation method thereof | |
CN102726565A (en) | Tartary buckwheat-chrysanthemum health-preserving tea and preparation method thereof | |
CN103229835A (en) | Wolfberry and jujube health promotion milk and preparation method of health promotion milk | |
CN103609696A (en) | Intelligence-promoting eyesight-improving type yoghourt and processing method thereof | |
CN106901115A (en) | A kind of hawthorn blueberry juice beverage and preparation method thereof | |
CN102048225B (en) | Red-date health protection beverage capable of improving growing development | |
CN103653144A (en) | Healthcare drink capable of improving immunity and preparation method thereof | |
CN109198550A (en) | A kind of food and preparation method thereof of bird's nest and flower glue combination | |
CN107307241A (en) | A kind of health care compound fruit vegetable drink and preparation method thereof | |
CN110226688A (en) | A kind of mulberries rhizoma polygonati drink and preparation method thereof | |
CN103695275B (en) | Method for preparing Korean-ginseng and sea cucumber wine | |
CN107083293A (en) | A kind of Yangtao wine and preparation method thereof | |
CN102038247A (en) | Chinese wolfberry sweet potato juice | |
CN112868946A (en) | Kiwi fruit compound beverage and preparation method thereof | |
CN107969586A (en) | A kind of lotus fermented beverage and production method | |
CN106689370A (en) | Method for preparing fruity yoghourt | |
CN106901082A (en) | Sea-buckthorn chitin prevents three beverages high | |
CN105341911A (en) | Processing method for pleurotus eryngii and rhizoma smilacis glabrae fermentation drink | |
CN101531957A (en) | Beer produced by the fermentation of black beans, Ningxia wolfberry, corn, and monascuspurpureus | |
CN104172376A (en) | Aloe and blueberry fruit granule beverage and preparation technology thereof | |
CN108967774A (en) | A kind of nectar and preparation method thereof | |
CN105961937B (en) | Functional food for preventing or relieving cancers and preparation method thereof | |
CN106318797A (en) | Okra health care wine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210601 |